Arrowstreet Capital’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.8M Sell
1,218,690
-181,766
-13% -$2.81M 0.01% 706
2025
Q1
$20.8M Sell
1,400,456
-2,815,917
-67% -$41.9M 0.02% 587
2024
Q4
$55.8M Sell
4,216,373
-419,019
-9% -$5.55M 0.04% 348
2024
Q3
$459K Buy
4,635,392
+2,319,877
+100% +$230K ﹤0.01% 1528
2024
Q2
$30M Buy
2,315,515
+950,588
+70% +$12.3M 0.03% 390
2024
Q1
$19M Sell
1,364,927
-543,294
-28% -$7.55M 0.02% 514
2023
Q4
$27.2M Sell
1,908,221
-565,689
-23% -$8.07M 0.03% 364
2023
Q3
$38.3M Buy
2,473,910
+139,715
+6% +$2.16M 0.05% 287
2023
Q2
$36.7M Buy
2,334,195
+1,276,920
+121% +$20.1M 0.04% 295
2023
Q1
$17.4M Sell
1,057,275
-2,847,021
-73% -$46.9M 0.02% 436
2022
Q4
$60.9M Buy
3,904,296
+2,465,178
+171% +$38.5M 0.09% 212
2022
Q3
$18.7M Buy
1,439,118
+406,032
+39% +$5.27M 0.03% 385
2022
Q2
$14.5M Buy
1,033,086
+871,373
+539% +$12.2M 0.02% 430
2022
Q1
$2.32M Buy
+161,713
New +$2.32M ﹤0.01% 779
2021
Q3
Sell
-87,700
Closed -$1.48M 1854
2021
Q2
$1.48M Sell
87,700
-173,431
-66% -$2.92M ﹤0.01% 1430
2021
Q1
$4.77M Buy
261,131
+29,953
+13% +$547K 0.01% 1197
2020
Q4
$4.21M Sell
231,178
-218,567
-49% -$3.98M 0.01% 1267
2020
Q3
$8.02M Sell
449,745
-84,833
-16% -$1.51M 0.01% 945
2020
Q2
$9.59M Buy
534,578
+119,577
+29% +$2.14M 0.02% 789
2020
Q1
$6.3M Buy
415,001
+371,118
+846% +$5.63M 0.02% 654
2019
Q4
$866K Buy
+43,883
New +$866K ﹤0.01% 1373
2019
Q2
Sell
-4,220,584
Closed -$86M 1687
2019
Q1
$86M Buy
4,220,584
+448,339
+12% +$9.13M 0.2% 110
2018
Q4
$63.4M Buy
+3,772,245
New +$63.4M 0.17% 140